Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Capital Expenditures (2020 - 2023)

Historic Capital Expenditures for Journey Medical (DERM) over the last 3 years, with Q1 2023 value amounting to $5.0 million.

  • Journey Medical's Capital Expenditures fell 7500.0% to $5.0 million in Q1 2023 from the same period last year, while for Dec 2023 it was $5.0 million, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $15.0 million for FY2024, which is 20000.0% up from last year.
  • Latest data reveals that Journey Medical reported Capital Expenditures of $5.0 million as of Q1 2023, which was down 7500.0% from $20.0 million recorded in Q1 2022.
  • Over the past 5 years, Journey Medical's Capital Expenditures peaked at $20.0 million during Q1 2022, and registered a low of $4.1 million during Q4 2020.
  • Over the past 3 years, Journey Medical's median Capital Expenditures value was $5.0 million (recorded in 2023), while the average stood at $9.7 million.
  • The largest annual percentage gain for Journey Medical's Capital Expenditures in the last 5 years was 7500.0% (2023), contrasted with its biggest fall of 7500.0% (2023).
  • Over the past 3 years, Journey Medical's Capital Expenditures (Quarter) stood at $4.1 million in 2020, then surged by 382.51% to $20.0 million in 2022, then crashed by 75.0% to $5.0 million in 2023.
  • Its Capital Expenditures stands at $5.0 million for Q1 2023, versus $20.0 million for Q1 2022 and $4.1 million for Q4 2020.